Translate this page into:
Juvenile Nasal Angiofibroma on 68Ga-DOTANOC PET/CT: Exploring Theranostic Avenues
Address for correspondence: Prof. Rakesh Kumar, Department of Nuclear Medicine, Division of Diagnostic Nuclear Medicine, All India Institute of Medical Sciences, New Delhi - 110 029, India. E-mail: rkphulia@yahoo.com
-
Received: ,
Accepted: ,
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Somatostatin (SST) cell surface receptors (SSTRs) are expressed in many different malignant, benign, and neuroendocrine tumors. SSTRs are also expressed in the endothelium of human vessels during angiogenesis and not in the nonproliferating vessels. We present a case of 19-year-old boy with juvenile nasal angiofibroma (JNA), who underwent 68Ga-DOTANOC PET/CT to explore SSTRs expression and theranostic potential. The scan revealed high uptake in the tumor, and in certain areas, the uptake was similar to that of the pituitary gland. Performance of DOTANOC PET/CT in JNA opens up new frontiers with respect to radiological staging, early recurrence identification, better delineation from postoperative scar tissue, possible preoperative treatment with SST analogs, and perhaps even radiopharmaceutical based-ligand therapy of inoperable/residual/recurrent JNAs in the future.
Keywords
Angiofibroma
DOTANOC positron emission tomography computed tomography
juvenile nasopharyngeal angiofibroma
A 19-year-old boy with an extensive clinicoradiologically diagnosed juvenile nasal angiofibroma (JNA) underwent 68Ga DOTANOC PET/CT scan to assess the somatostatin (SST) cell surface receptors (SSTRs) expression and to explore its theranostic potential. Only head-and-neck spot imaging was obtained to limit radiation exposure as the tumor is benign. The scan revealed heterogeneously increased tracer uptake in the soft tissue mass lesion, involving the right nasal cavity, the nasopharynx, and the ethmoid and sphenoid sinus (SUVmax3.3). The lesion was extending into the right pterygopalatine and infratemporal fossa causing the characteristic anterior bowing of posterior wall of the maxilla [“Holman miller antral bowing sign,” arrow in Figure 1d]. The uptake was intense in certain areas of the tumors, similar to the uptake of pituitary gland (SUVmax3.6), concordant with the distribution of SSTRs. In addition, the intracranial extent of the tumor could be clearly demarcated as there was no uptake in the brain except for pituitary gland (axial, coronal, and sagittal PET [Figure 1a–c], CT [Figure 1d–f, and fused PET/CT images [Figure 1g–i], respectively). The patient underwent surgical excision and the histopathology confirmed JNA.

SST is a short peptide hormone with numerous autocrine, paracrine, and neurotransmitter regulatory functions.[1] SSTRs are expressed in many different malignant, benign, and neuroendocrine tumors. SSTRs are also expressed in the endothelium of human vessels during angiogenesis and not in the nonproliferating vessels.[23] Hence, SSTRs expression may be expected in juvenile nasopharyngeal angiofibroma (JNA), an uncommon locally aggressive benign fibrovascular neoplasm arising from the posterior part of the nasal cavity in adolescent males.[45] Gronkiewicz et al. described their findings in a group of 6 patients with juvenile nasal angiofibroma, in whom the 68Ga-DOTATATE PET data were correlated with immunohistochemistry for SST receptors.[6] Performance of DOTANOC PET/CT in JNA opens up new frontiers with respect to radiological staging, early recurrence identification, better delineation from postoperative scar tissue, possible preoperative treatment with SST analogs, and perhaps even peptide receptor-ligand therapy of inoperable/residual/recurrent JNAs in the future.
Informed consent
Informed consent was obtained from all individual participants included in the prospective clinical study (IECPG-432/27.06.2019), including the patient presented in this case report. A separate consent from the patient was obtained for publication of the case report.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995;16:86-8.
- [Google Scholar]
- Expression of somatostatin receptors in peritumoral veins of human tumors. Cancer. 1999;85:188-98.
- [Google Scholar]
- (99m) TC-octreotide scintigraphy and somatostatin receptor subtype expression in juvenile nasopharyngeal angiofibromas. Head Neck. 2011;33:1739-46.
- [Google Scholar]
- Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head Neck. 2017;39:1033-45.
- [Google Scholar]
